Shares of Bioventix PLC (LON:BVXP – Get Free Report) reached a new 52-week low on Wednesday . The company traded as low as GBX 2,704 ($33.67) and last traded at GBX 2,850 ($35.49), with a volume of 12438 shares traded. The stock had previously closed at GBX 2,900 ($36.11).
Bioventix Stock Down 1.7 %
The firm has a market capitalization of £148.77 million, a PE ratio of 1,748.47 and a beta of 0.35. The company’s 50-day simple moving average is GBX 3,271.18 and its 200 day simple moving average is GBX 3,718.91.
Insider Buying and Selling at Bioventix
In other Bioventix news, insider Bruce Hiscock acquired 24 shares of the business’s stock in a transaction dated Friday, November 22nd. The stock was acquired at an average cost of GBX 3,822 ($47.59) per share, for a total transaction of £917.28 ($1,142.17). 8.02% of the stock is owned by corporate insiders.
About Bioventix
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.
Featured Stories
- Five stocks we like better than Bioventix
- What Are Some of the Best Large-Cap Stocks to Buy?
- 3 Reasons Micron Stock Is Deeply Undervalued Right Now
- What is the Dow Jones Industrial Average (DJIA)?
- Inflation Persists, But So Do Stock Opportunities: Rally On
- What Does Downgrade Mean in Investing?
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
Receive News & Ratings for Bioventix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioventix and related companies with MarketBeat.com's FREE daily email newsletter.
